Close Notification

Your cart does not contain any items

Precision Medicine in Oncology

Bulent Aydogan James A. Radosevich



Not in-store but you can order this
How long will it take?


22 October 2020
A FRESH EXAMINATION OF PRECISION MEDICINE'S INCREASINGLY PROMINENT ROLE IN THE FIELD OF ONCOLOGY Precision medicine takes into account each patient's specific characteristics and requirements to arrive at treatment plans that are optimized towards the best possible outcome. As the field of oncology continues to advance, this tailored approach is becoming more and more prevalent, channelling data on genomics, proteomics, metabolomics and other areas into new and innovative methods of practice. Precision Medicine in Oncology draws together the essential research driving the field forward, providing oncology clinicians and trainees alike with an illuminating overview of the technology and thinking behind the breakthroughs currently being made. Topics covered include:

Biologically-guided radiation therapy Informatics for precision medicine Molecular imaging Biomarkers for treatment assessment Big data Nanoplatforms Casting a spotlight on this emerging knowledge base and its impact upon the management of tumors, Precision Medicine in Oncology opens up new possibilities and ways of working not only for oncologists, but also for molecular biologists, radiologists, medical geneticists, and others.
Edited by:   Bulent Aydogan, James A. Radosevich
Imprint:   Wiley-Blackwell
Country of Publication:   United States
Dimensions:   Height: 261mm,  Width: 167mm,  Spine: 19mm
Weight:   1.420kg
ISBN:   9781119432449
ISBN 10:   1119432448
Pages:   288
Publication Date:   22 October 2020
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
List of Contributors Preface List of Abbreviations Chapter 1 Genomic Strategies for Personalized Cancer Therapy Chapter 2 Blood-based biomarkers for the diagnosis and prognosis of cancer Chapter 3 Application of circulating cell free DNA for personalized cancer therapy Chapter 4 Prognostic Implications of EGFR, p53, p16, cyclin D1, Bcl-2 in Head & Neck Squamous Cell Carcinoma (HNSCC) Chapter 6 Predictive and prognostic markers for cancer medicine Chapter 7 Dual Energy Imaging in Precision Radiation Therapy Chapter 8 The role of Big Data in personalized medicine

Bulent Aydogan, PhD, Associate Professor, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA. James Radosevich, PhD, Professor, Department of Oral Medicine and Diagnostic Sciences, University of Illinois at Chicago, Chicago, IL, USA.

See Also